- Home
- AEHR vs PHAT Comparison
AEHR vs PHAT Comparison
Compare AEHR & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEHR
- PHAT
- Stock Information
- Founded
- AEHR 1977
- PHAT 2018
- Country
- AEHR United States
- PHAT United States
- Employees
- AEHR N/A
- PHAT N/A
- Industry
- AEHR Electrical Products
- PHAT Biotechnology: Pharmaceutical Preparations
- Sector
- AEHR Industrials
- PHAT Health Care
- Exchange
- AEHR Nasdaq
- PHAT Nasdaq
- Market Cap
- AEHR 974.9M
- PHAT 835.7M
- IPO Year
- AEHR 1997
- PHAT 2019
- Fundamental
- Price
- AEHR $25.85
- PHAT $10.75
- Analyst Decision
- AEHR
- PHAT Strong Buy
- Analyst Count
- AEHR 0
- PHAT 5
- Target Price
- AEHR N/A
- PHAT $16.40
- AVG Volume (30 Days)
- AEHR 2.0M
- PHAT 1.2M
- Earning Date
- AEHR 10-06-2025
- PHAT 11-06-2025
- Dividend Yield
- AEHR N/A
- PHAT N/A
- EPS Growth
- AEHR N/A
- PHAT N/A
- EPS
- AEHR N/A
- PHAT N/A
- Revenue
- AEHR $56,818,000.00
- PHAT $114,039,000.00
- Revenue This Year
- AEHR $6.19
- PHAT $213.11
- Revenue Next Year
- AEHR $33.87
- PHAT $91.84
- P/E Ratio
- AEHR N/A
- PHAT N/A
- Revenue Growth
- AEHR N/A
- PHAT 1049.82
- 52 Week Low
- AEHR $6.27
- PHAT $2.21
- 52 Week High
- AEHR $34.35
- PHAT $19.50
- Technical
- Relative Strength Index (RSI)
- AEHR 44.38
- PHAT 42.71
- Support Level
- AEHR $29.41
- PHAT $11.74
- Resistance Level
- AEHR $34.35
- PHAT $12.97
- Average True Range (ATR)
- AEHR 2.38
- PHAT 0.85
- MACD
- AEHR -0.65
- PHAT -0.10
- Stochastic Oscillator
- AEHR 29.43
- PHAT 17.92
About AEHR Aehr Test Systems
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.